Treatment with Electromagnetic Fields Reverses the Long-Term Clinical Course of a Patient with Chronic Progressive Multiple Sclerosis

References

• Adey W. Tissue interactions with nonionizing EM fields. Physiological reviews 1981; 61: 435–505
   PubMed Web of Science ®Google Scholar
• Albertson T. E., Peterson S. L., Stark L. C., Lakin M. L., Winters W. D. The anticonvulsant properties of melatonin on kindled seizures in rats. Neuropharmacology 1981; 20: 61–66
   PubMed Web of Science ®Google Scholar
• Augeli A., Gatti G., Sartori M. L., DelPonte D., Garagnola R. Effect of exogenous melatonin on human natural killer (NK) cell activity: an approach to the immunomodulatory role of the pineal gland. The pineal gland and cancer, D. Gupta, A. Attanasio, R. J. Reiter. Brain Research Promotion, London 1988
   Google Scholar
• Anlon-Tay F., Chou C., Anton S., Wurtman R. J. Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMedGoogle Scholar
• Barasi S., Roberts M. H. T. The action of 5-hydroxytryplamine antagonists and precursors on bulbospinal facilitation of spinal reflexes. Brain Research 1973; 52: 385–388
   PubMed Web of Science ®Google Scholar
• Bauer H. J. Problems of symptomatic therapy in multiple sclerosis. Neurology 1978; 28: 8–20
   PubMed Web of Science ®Google Scholar
• Baumgarten H. G., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatrie 1985; 18: 180–187
   PubMed Web of Science ®Google Scholar
• Bawin S. M., Adey W. R. Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proceedings of the National Academy of Sciences, USA 1976; 73: 1999–2003
   PubMed Web of Science ®Google Scholar
• Beatty P. A., Goodkin D. E., Beatty P. A., Monson N. Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosis. Brain and Cognition 1989; 11: 73–86
   PubMed Web of Science ®Google Scholar
• Berger J., Sheremata W. Persistent neurological deficit precipitated by hot bath test in MS. Journal of the American Medical Association 1983; 249: 1751–1753
   PubMed Web of Science ®Google Scholar
• Bindoni M., Rizzo R. Hippocampal evoked potentials and convulsive activity after electrolytic lesions of the pineal body in chronic experiments in rabbits. Archives of Science and Biology 1965; 49: 223–233
   PubMedGoogle Scholar
• Blackman C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity. sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss, New York 1988
   Google Scholar
• Borgens R. B., Roeder E., Cohen M. J. Enhanced spinal cord regeneration in lampery by applied electric fields. Science 1981; 213: 611–617
   PubMed Web of Science ®Google Scholar
• Broman T. Blood brain barrier damage in multiple sclerosis: supra-vital test observations. Acta Neurologica Scandinavica 1964; 40(Suppl 10)21–24
   PubMedGoogle Scholar
• Cohen D. First measurements of the magnetic field of a nerve impulse. Science 1972; 175: 664–666
   PubMed Web of Science ®Google Scholar
• Devoino L., Idova G., Alperina E., Cheido M. (1987) Distribution of immunocompetent cells underlying psychoneuroimmunomodulation. Brain neuromediator control mechanisms. Neuroimmune interactions. Proceedings of the second international workshop on neuroimmunomodulation. 1987, B. D. Jankovic, B. M. Markovic, N. H. Spector. Annals of the New York Academy of Sciences, 496: 292–300
   Google Scholar
• Ellison G. W., Myers L. W., Tourtellotte W. W., Baumhefner R. W. Status of immunosuppressive treatment of multiple sclerosis. Multiple sclerosis; current status of research and treatment, R. M. Herndon, F. J. Seil. Demos Publications, New York 1994; 175–187
   Google Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal gland: anatomy, physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Essman W. B. Serotonin in seizures and seizure disorders. Serotonin in health and disease: the central nervous system, W. B. Essman. Spectrum, New York 1978; vol. 3: 317–401
   Google Scholar
• Franklin G. M., Nelson L. M., Filley C. M., Heaton R. K. Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology 1989; 46: 162–167
   PubMed Web of Science ®Google Scholar
• Gareri P., Mattace R., Nava F., De Sarro G. Role of calcium in brain aging. General Pharmacology 1995; 26: 1651–1657
   PubMedGoogle Scholar
• Giesser B. Multiple sclerosis. Current concepts in management. Drugs 1985; 29: 88–95
   PubMed Web of Science ®Google Scholar
• Hall N. R., Goldstein A. L. Neurotransmitters and the immune system. Psychoneuroimmunology, R. Ader. Academic Press, San Diego 1981; 521–543
   Google Scholar
• Heaton R. K., Nelson L. M., Thompson D. S. Neuropsychological findings in relapsing remitting and chronic progressive multiple sclerosis. Journal of Consulting Clinical Psychology 1985; 53: 103–110
   PubMed Web of Science ®Google Scholar
• Hughes R. A. C. Prospects for the treatment of multiple sclerosis. Journal of the Royal Society of Medicine 1991; 84: 63–65
   PubMed Web of Science ®Google Scholar
• Jacobs B. L. Serotonin and behavior: emphasis on motor control. Journal of Clinical Psychiatiy 1991; 52(12, suppl)17–23
   PubMedGoogle Scholar
• Jacobs B. L. Serotonin, motor activity and depression-related disorders. American Scientist 1994; 82: 456–463
   Web of Science ®Google Scholar
• Jacobs B. L., Fornal C. A. 5-HT and motor control: a hypothesis. Trends in Neurosciences 1993; 16: 346–352
   PubMed Web of Science ®Google Scholar
• Jankovic B. D., Isakovic K., Petrovic S. Effect of pinealectomy on immune reactions in the rat. Immunology 1970; 18: 1–5
   PubMed Web of Science ®Google Scholar
• Kaczmarek L., Adey W. Weak electric gradient change ionic and transmitter fluxes in cortex. Brain Research 1974; 66: 537–540
   Web of Science ®Google Scholar
• Koopmans R. A., Li D. K. B., Oger J. J. F., Mayo J., Paty D. W. The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 1989; 39: 959–963
   PubMed Web of Science ®Google Scholar
• Kraft G. H., Freal J. E., Coryell J. K. Multiple sclerosis: early prognostic guidelines. Journal of Chronic Disease 1977; 30: 819–830
   PubMedGoogle Scholar
• Kurtzke J. F., Beebe G. W., Nagler B. Studies in the natural history of multiple sclerosis, 8. Early prognostic features of the later course of the illness. Journal of Chronic Disease 1977; 30: 819–830
   PubMedGoogle Scholar
• Kyuhou S. I., Okada Y. C. Detection of magnetic evoked fields associated with synchronous population activities in the transverse CA1 slice of the guinea pig. Journal of Neurophysiology 1993; 70: 2665–2668
   PubMed Web of Science ®Google Scholar
• Leibowitz U., Kahana E., Alter M. Multiple sclerosis in immigrant and native populations of Israel. Lancet 1969; 2: 1323
   PubMedGoogle Scholar
• Luben R. A. Effects of low-energy electromagnetic fields (pulsed and DC) on membrane signal transduction processes in biological systems. Health Physics 1991; 61: 15–28
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M. The immunoendocrine role of melatonin. Journal of Pineal Research 1993; 14: 1–10
   PubMed Web of Science ®Google Scholar
• Miguez J. M., Martin F. J., Aldegunde M. Effects of single doses and daily melatonin treatments on serotonin metabolism in rat brain regions. Journal of Pineal Research 1994; 17: 170–176
   PubMed Web of Science ®Google Scholar
• Minderhoud J. M., van der Hoeven J. H., Prange A. J. A. Course and prognosis of chronic progressive multiple sclerosis. Acta Neurologica Scandinavica 1988; 78: 10–15
   PubMed Web of Science ®Google Scholar
• Nir I., Behroozi K., Assael M., Ivriani I., Suiman F. G. Changes in the electrical activity of the brain following pinealectomy. Neuroendocrinology 1969; 4: 122–127
   PubMed Web of Science ®Google Scholar
• Noseworthy J., Paty D., Wonnacott T. Multiple sclerosis after age 50. Neurology 1983; 33: 1537–1544
   PubMedGoogle Scholar
• O'Brien D. J., Hughes F. W., Newberne J. Influence of lysergic acid diethylamide on experimental allergic encephalomyelitis. Proceedings of the Society for Experimental Biology 1962; 111: 490–493
   Web of Science ®Google Scholar
• Okada Y. C., Lauritzen M., Nicholson C. Magnetic field associated with neural activities in an isolated cerebellum. Brain Research 1987; 412: 151–155
   PubMed Web of Science ®Google Scholar
• Pazo J. H. Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Research Bulletin 1979; 4: 725–730
   PubMed Web of Science ®Google Scholar
• Pierpaoli W., Maestroni G. J. M. Neuroimmunomodulation: some recent views and findings. InternationalJournalofNeuroscience 1988; 39: 25–33
   Google Scholar
• Politis M. J., Zanakis M. F., Albala B. J. Mammalian optic nerve regeneration following the application of electric fields. The Journal of Trauma 1988; 28: 1548–1552
   PubMedGoogle Scholar
• Poser C. M. The pathogenesis of MS: a critical reappraisal. Acta Neuropathologica 1986; 71: 1–10
   PubMedGoogle Scholar
• Poser C. M. Multiple sclerosis, observations and reflections-a personal memoir. Journal of the Neurological Sciences 1992; 107: 127–140
   PubMed Web of Science ®Google Scholar
• Relkin R., Schneck L. Effects of pinealectomy on rat brain myelin. Proceedings of the Society for Experimental Biology and Medicine 1975; 148: 337–338
   PubMed Web of Science ®Google Scholar
• Relkin R., Fok W. Y., Schneck L. Pinealectomy and brain myelination. Endocrinology 1973; 92: 1426–1428
   PubMed Web of Science ®Google Scholar
• Roldan E., Anton-Tay F. EEG and convulsive threshold changes produced by pineal extract administration. Brain Research 1968; 11: 238–245
   PubMedGoogle Scholar
• Rudick R. A., Goodkin D. E., Ransohoff R. M. Pharmacotherapy of multiple sclerosis: current status. Cleveland Clinic Journal of Medicine 1992; 59: 267–277
   PubMed Web of Science ®Google Scholar
• Rudolph K., Wirz-Justice A., Krauchi K., Feer H. Static magnetic fields decrease nocturnal pineal cAMP in the rat. Brain Research 1988; 446: 159–160
   PubMed Web of Science ®Google Scholar
• Rusovan A., Kanje M., Mild K. H. The stimulatory effect of magnetic fields on regeneration of the rat sciatic nerve is frequency dependent. Experimental Neurology 1992; 117: 81–84
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields. International Journal of Neuroscience 1995a; 82: 223–242
   PubMed Web of Science ®Google Scholar
• Sandyk R. Long term beneficial effects of weak electromagnetic fields in multiple sclerosis. International Journal of Neuroscience 1995b; 83: 45–57
   PubMed Web of Science ®Google Scholar
• Sandyk R. Treatment with electromagnetic fields alters the clinical course of chronic progressive multiple sclerosis: a case report. International Journal of Neuroscience 1996; 88: 75–82
   PubMed Web of Science ®Google Scholar
• Sandyk R. Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis. International Journal of Neuroscience
   Google Scholar
• Sandyk R. Influence of the pineal gland on the expression of experimental allergic encephalomyelitis: Possible relationship to the acquisition of multiple sclerosis. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience 1992; 67: 173–186
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience 1993; 68: 227–240
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience 1993; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Dann L. C. Weak electromagnetic fields attenuate tremor in multiple sclerosis. International Journal of Neuroscience 1994; 79: 199–212
   PubMed Web of Science ®Google Scholar
• Schuller E., Delasnerie N., Deloche G., Loridan M. Multiple sclerosis: a two phase disease?. Acta Neurologica Scandinavica 1973; 49: 453–460
   PubMedGoogle Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moor-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Sharma H. S., Dey P. K. Influence of long term immobilization stress on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. Journal of Neurological Sciences 1986a; 72: 61–76
   PubMed Web of Science ®Google Scholar
• Sharma H. S., Dey P. K. Probable involvement of 5-hydroxytryptamine in increased permeability of blood brain barrier under heat stress in young rats. Neuropharmacology 1986b; 25: 161–167
   PubMed Web of Science ®Google Scholar
• Sirvio J., Riekkinen P., Jakala P., Riekkinen P. J. Experimental studies on the role of serotonin in cognition. Progress in Neurobiology 1994; 43: 363–379
   PubMed Web of Science ®Google Scholar
• Sisken B. F., Kanje M., Lundborg G., Herbst E., Kurtz W. Stimulation of rat sciatic nerve regeneration with pulsed electromagnetic fields. Brain Research 1989; 489: 309–316
   Google Scholar
• Smith C. R., Scheinberg L. C. Clinical features of multiple sclerosis. Seminars in Neurology 1985; 5: 85–93
   Google Scholar
• Stoupel E., Keret R., Assa S., Kaufman H., Shimshoni M., Laron Z. Secretion of growth hormone, prolactin and corticosteroids during different levels of geomagnetic activity. Neuroendocrine Letters 1983; 5: 365
   Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Sugden D. Psychopharmacological effects of melatonin in mouse and rat. Journal of Pharmacology and Experimental Therapeutics 1983; 227: 587–591
   PubMed Web of Science ®Google Scholar
• Trabulsi R., Pawlowski B., Wieraszko A. The influence of steady magnetic fields on the mouse hippocampal evoked potentials in vitro. Brain Research 1996; 728: 135–139
   PubMed Web of Science ®Google Scholar
• Wallis D. I. 5-HT receptors involved in initiation or modulation of motor patterns: opportunities for drug development. Trends in Pharmacological Sciences 1994; 15: 288–292
   PubMed Web of Science ®Google Scholar
• Weiner H. L., Hafler D. A. Immunotherapy of multiple sclerosis. Annals of Neuroloy 1988; 23: 211–222
   PubMed Web of Science ®Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Westergaard E. Ultrastructural permeability properties of cerebral microvasculature under normal and experimental conditions after applications of tracers. Advances in Neurology 1980; 28: 55–74
   PubMedGoogle Scholar
• Wilson B. W., Chess E. K., Anderson L. E. 60-Hz electric-field effects on pineal melatonin rhythms: time course for onset and recovery. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Neuroendocrine mediated effects of electromagnetic field exposure: possible role of the pineal gland. Life Sciences 1989; 45: 1319–1332
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Effects of electromagnetic field exposure on neuroendocrine function. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 29–50
   Google Scholar
• Whitaker J. N., Benveniste E. N. Demyelinating diseases. Neurobiology of disease, A. L. Pearlman, R. C. Collins. Oxford University Press, New York 1990
   Google Scholar
• Zecca L., Ferrario P., Margonato V., Cerretelli P., Zonta N. Neurotransmitter amino acid variations in stratum of rats exposed to 50Hz electric fields. Biochemistry, Biphysics Acta 1991; 1075: 1–5
   PubMed Web of Science ®Google Scholar
• Zeise M. L., Semm P. Melatonin lowers excitability of guinea pig hippocampal neurons in vitro. Journal of Comparative Physiology 1985; 157: 23–29
   PubMed Web of Science ®Google Scholar